We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Researchers from South Korea and the United States have developed a drug delivery technology that can effectively suppress lung inflammation and tissue damage caused by COVID-19 infection.
